scholarly article | Q13442814 |
P2093 | author name string | Alexander T Cohen | |
Frederick A Anderson | |||
John A Heit | |||
Dogan Fidan | |||
Maxim Zayaruzny | |||
P433 | issue | 9 | |
P921 | main subject | patient | Q181600 |
P304 | page(s) | 777-782 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | American Journal of Hematology | Q4744246 |
P1476 | title | Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. | |
P478 | volume | 82 |
Q39422955 | A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents |
Q38129188 | A review of venous thromboembolism prophylaxis for hospitalized medical patients. |
Q37417509 | A systematic review of Cochrane anticoagulation reviews. |
Q35852893 | A validated risk model to predict 90-day VTE events in postsurgical patients |
Q38810165 | Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study |
Q46112560 | An assessment of surgical thromboprophylaxis in a tertiary care center. |
Q37419638 | Ankylosing spondylitis and risk of venous thromboembolism: A systematic review and meta-analysis |
Q39958476 | Appropriate VTE prophylaxis is associated with lower direct medical costs |
Q33722129 | Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). |
Q39942623 | Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis? |
Q38772826 | Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. |
Q38405442 | Association of Sarcoidosis With Increased Risk of VTE: A Population-Based Study, 1976 to 2013. |
Q90441536 | Associations between Peripheral Thromboembolic Vascular Disease and Androgen Deprivation Therapy in Asian Prostate Cancer Patients |
Q91770692 | Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults |
Q38514907 | Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 2--Lower airway, thromboembolic, and inflammatory diseases |
Q90712371 | Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States |
Q36298714 | Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery |
Q42718620 | Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism |
Q34994523 | Economic burden of venous thromboembolism in hospitalized patients |
Q51759037 | Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. |
Q89002090 | Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism |
Q90546544 | Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals |
Q41495478 | Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding |
Q27003914 | Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes? |
Q49679442 | Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis |
Q35114937 | External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system |
Q57070668 | Fever is associated with higher morbidity and clot burden in patients with acute pulmonary embolism |
Q35776374 | Frequency, cost, and risk factors of readmissions among severe sepsis survivors |
Q51035409 | Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil. |
Q50956895 | Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil. |
Q89436308 | Highlights: burden of venous thromboembolism and role of extended-duration thromboprophylaxis in acute medically ill patients |
Q55209378 | INR Stability, Clinical Importance, and Predictors in Patients With Atrial Fibrillation and Venous Thromboembolism Receiving Vitamin K Antagonists. |
Q37877058 | Identification of patient venous thromboembolism risk across the continuum of care |
Q38095855 | Impact of a venous thromboembolism prophylaxis "smart order set": Improved compliance, fewer events. |
Q28651190 | Impact of thromboprophylaxis across the US acute care setting |
Q41716605 | Implementation of a mandated venous thromboembolism clinical order set improves venous thromboembolism core measures |
Q36981761 | Implementation of vertical clinical pharmacist service on venous thromboembolism prophylaxis in hospitalized medical patients |
Q40212061 | Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium |
Q42105287 | Improving adherence to venous thromoembolism prophylaxis using multiple interventions |
Q83527973 | Improving venous thromboembolism prevention processes and outcomes at a community hospital |
Q40785891 | Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry |
Q37249802 | Inferior vena cava filter insertion through the popliteal vein: enabling the percutaneous endovenous intervention of deep vein thrombosis with a single venous access approach in a single session |
Q30664606 | Inferior vena cava filtration in the management of venous thromboembolism: filtering the data |
Q46801023 | Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries |
Q53403458 | Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. |
Q37604594 | Lack of Clinical Benefit of Thromboprophylaxis in Patients Hospitalized in a Medical Unit Over a 10-year Span |
Q37001368 | Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults |
Q46068141 | Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease |
Q35070627 | Multilocus genetic risk scores for venous thromboembolism risk assessment |
Q35494098 | Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes |
Q38239190 | Nuclear medicine and the emergency department patient: an illustrative case-based approach |
Q37641259 | Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement |
Q84343015 | Performance measures for improving the prevention of venous thromboembolism: achievement in clinical practice |
Q37627200 | Physician alerts to prevent venous thromboembolism |
Q40120884 | Post-Hospital Discharge Venous Thromboembolism in Colorectal Surgery. |
Q37599535 | Practices to prevent venous thromboembolism: a brief review. |
Q90016082 | Prevalence of Risk Factors for Hospital-Acquired Venous Thromboembolism in Neurosurgery and Orthopedic Spine Surgery Patients |
Q38315654 | Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing |
Q61455653 | Processing of Electronic Medical Records for Health Services Research in an Academic Medical Center: Methods and Validation |
Q89857612 | Prognostic factors for VTE and Bleeding in Hospitalized Medical Patients: a systematic review and meta-analysis |
Q83943627 | Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study |
Q38079539 | Rationale supporting an "opt-out" policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients |
Q55419410 | Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis. |
Q89041009 | Reduction in physical function in women after venous thromboembolism |
Q41472249 | Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients |
Q30248249 | Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis |
Q38095824 | Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism |
Q55345178 | Sabemos prescrever profilaxia de tromboembolismo venoso nos pacientes internados? |
Q33418566 | Safety of early pharmacological thromboprophylaxis after subarachnoid hemorrhage |
Q37959156 | Strategies for venous thromboembolism prophylaxis programs |
Q46507540 | Sublingual administration of warfarin: a novel form of delivery |
Q37777972 | The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies |
Q93356147 | Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review |
Q55710072 | Treatment of high- and intermediate-risk pulmonary embolism using the AngioJet percutaneous mechanical thrombectomy system in patients with contraindications for thrombolytic treatment - a pilot study. |
Q51797008 | Venous thromboembolic events in hospitalised medical patients. |
Q33385180 | Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey |
Q37074678 | Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study |
Q47587837 | Venous thromboembolism risks and prophylaxis in King Fahad Hospital, Madinah, Saudi Arabia |
Search more.